Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 工學院
  3. 醫學工程學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79147
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor楊台鴻(Tai-Horng Young)
dc.contributor.authorYu-Chen Huangen
dc.contributor.author黃俞禎zh_TW
dc.date.accessioned2021-07-11T15:47:53Z-
dc.date.available2023-08-06
dc.date.copyright2018-08-06
dc.date.issued2018
dc.date.submitted2018-08-02
dc.identifier.citation1. Davis, Erica C., and Valerie D. Callender. 'Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color.' The Journal of clinical and aesthetic dermatology 3.7 (2010): 20.
2. Sofen, Bryan, Giselle Prado, and Jason Emer. 'Melasma and post inflammatory hyperpigmentation: Management update and expert opinion.' Skin Therapy Lett 21.1 (2016): 1-7.
3. Borovanský, Jan, and Milan Elleder. 'Melanosome degradation: fact or fiction.' Pigment Cell & Melanoma Research 16.3 (2003): 280-286.
4. Tziotzios, Christos, Christos Profyris, and Jane Sterling. 'Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics: part II. Strategies to reduce scar formation after dermatologic procedures.' Journal of the American Academy of Dermatology 66.1 (2012): 13-24.
5. Verderio, E. A. M., T. Johnson, and M. Griffin. 'Tissue transglutaminase in normal and abnormal wound healing.' Amino acids 26.4 (2004): 387-404.
6. Patel, Girish K., et al. 'Numerous keratinocyte subtypes involved in wound re-epithelialization.' Journal of investigative dermatology 126.2 (2006): 497-502.
7. Breathnach, Aodán S. 'Melanocytes in Early Regenerated Human Epidermis** From the Department of Anatomy, St. Mary's Hospital Medical School, London, W. 2., England.' Journal of Investigative Dermatology 35.4 (1960): 245-251.
8. Park, Hee-Young, and Mina Yaar. 'Chapter 72. Biology of Melanocytes' Fitzpatrick's Dermatology in General Medicine, 8e. The McGraw-Hill Companies: New York, NY. (2012)
9. Seiberg, Miri. 'Keratinocyte–melanocyte interactions during melanosome transfer.' Pigment Cell & Melanoma Research 14.4 (2001): 236-242.
10. Ng, Wei Long, Wai Yee Yeong, and May Win Naing. 'Cellular approaches to tissue-engineering of skin: a review.' Journal of Tissue Science & Engineering 6.2 (2015): 1.
11. Pillaiyar, Thanigaimalai, Manoj Manickam, and Vigneshwaran Namasivayam. 'Skin whitening agents: Medicinal chemistry perspective of tyrosinase inhibitors.' Journal of enzyme inhibition and medicinal chemistry 32.1 (2017): 403-425.
12. Halaban, Ruth, et al. 'Abnormal acidification of melanoma cells induces tyrosinase retention in the early secretory pathway.' Journal of Biological Chemistry 277.17 (2002): 14821-14828.
13. Mescher, A.L. 'Skin.' Junqueira's Basic Histology, 14e. McGraw-Hill Education: New York, NY. (2016)
14. Ando, Hideya, et al. 'Melanosomes are transferred from melanocytes to keratinocytes through the processes of packaging, release, uptake, and dispersion.' Journal of Investigative Dermatology 132.4 (2012): 1222-1229.
15. Hruza, Luciann Lisi, and Alice P. Pentland. 'Mechanisms of UV-induced inflammation.' Journal of Investigative Dermatology 100.1 (1993): S35-S41.
16. Chan, Chin-Feng, et al. 'Fermented broth in tyrosinase-and melanogenesis inhibition.' Molecules 19.9 (2014): 13122-13135.
17. Leurs, Regorius, M. J. Smit, and H. Timmerman. 'Molecular pharmacological aspects of histamine receptors.' Pharmacology & therapeutics 66.3 (1995): 413-463.
18. Lassalle, Michael W., et al. 'Effects of Melanogenesis‐Inducing Nitric Oxide and Histamine on the Production of Eumelanin and Pheomelanin in Cultured Human Melanocytes.' Pigment Cell & Melanoma Research 16.1 (2003): 81-84.
19. Chadwick, Sarah, Rebecca Heath, and Mamta Shah. 'Abnormal pigmentation within cutaneous scars: A complication of wound healing.' Indian journal of plastic surgery: official publication of the Association of Plastic Surgeons of India 45.2 (2012): 403.
20. Loeken, Mary R. 'How TGF‐β and PAX3 regulate suntanning.' Pigment cell & melanoma research 22.2 (2009): 146-147.
21. Majid, Imran. 'Mometasone-based triple combination therapy in melasma: Is it really safe?.' Indian journal of dermatology 55.4 (2010): 359.
22. Arora, Pooja, et al. 'Lasers for treatment of melasma and post-inflammatory hyperpigmentation.' Journal of cutaneous and aesthetic surgery 5.2 (2012): 93.
23. Ortonne, Jean-Paul, and Donald L. Bissett. 'Latest insights into skin hyperpigmentation.' Journal of Investigative Dermatology Symposium Proceedings 13.1 (2008): 10-14
24. Chen, Hsi-Wen. 'The Modulation Effects of Chitosan on Melanin Synthesis and Melanosomes Uptake.' Institute of Biomedical Engineering, National Taiwan University (2015)
25. Lee, Shu-Mei, et al. 'Chitosonic® acid as a novel cosmetic ingredient: Evaluation of its antimicrobial, antioxidant and hydration activities.' Materials 6.4 (2013): 1391-1402.
26. Bissett, Donald L., et al. 'Reduction in the appearance of facial hyperpigmentation by topical N‐acetyl glucosamine.' Journal of cosmetic dermatology 6.1 (2007): 20-26.
27. Greatens, Amanda, et al. 'Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible.' Experimental dermatology 14.7 (2005): 498-508.
28. Masaki, Hitoshi. 'Role of antioxidants in the skin: anti-aging effects.' Journal of dermatological science 58.2 (2010): 85-90.
29. Farris, Patricia K. 'Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions.' Dermatologic surgery 31.s1 (2005): 814-818.
30. Hata, Ryu‐Ichiro, and Haruki Senoo. 'L‐ascorbic acid 2‐phosphate stimulates collagen accumulation, cell proliferation, and formation of a three‐dimensional tissuelike substance by skin fibroblasts.' Journal of cellular physiology 138.1 (1989): 8-16.
31. Stamford, Nicholas PJ. 'Stability, transdermal penetration, and cutaneous effects of ascorbic acid and its derivatives.' Journal of cosmetic dermatology11.4 (2012): 310-317.
32. Ruzainah, Ali Jaafar, et al. 'Proximate analysis of dragon fruit (Hylecereus polyhizus).' American Journal of Applied Sciences 6.7 (2009): 1341-1346.
33. Tabata, Yasuhiko, and Yoshito Ikada. 'Protein release from gelatin matrices.' Advanced drug delivery reviews 31.3 (1998): 287-301.
34. Chadwick, Sarah L., et al. 'Repigmentation of cutaneous scars depends on original wound type.' Journal of anatomy 223.1 (2013): 74-82.
35. Wong, Victor W., and Geoffrey C. Gurtner. 'Tissue engineering for the management of chronic wounds: current concepts and future perspectives.' Experimental dermatology 21.10 (2012): 729-734.
36. Lee, Chang Seok, et al. 'Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MITF degradation.' Journal of Investigative Dermatology 133.4 (2013): 1063-1071.
37. Kim, Jin Hee, et al. 'Downregulation of melanin synthesis by haginin A and its application to in vivo lightening model.' Journal of Investigative Dermatology128.5 (2008): 1227-1235.
38. Yokota, Tomohiro, et al. 'The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation.' Pigment Cell & Melanoma Research 11.6 (1998): 355-361.
39. Guttman, David E., and Dana Brooke. 'Solution phase interaction of nicotinamide with ascorbic acid.' Journal of pharmaceutical sciences 52.10 (1963): 941-945.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/79147-
dc.description.abstract本研究欲發展一種整合各種能在黑色素生成及沈澱的不同階段進行抑制的試劑及傷口修復試劑的褪黑修復凝膠(APH gel),並從傷口照護的早期至後期階段來預防及治療傷口發炎反應所引起的發炎後過分黑色素沈澱(PIH)。首先,我們利用B16F10黑色素瘤細胞與人類黑色素細胞-角質細胞共培養系統測試了一些鎖定的美白成分,包含幾丁聚醣的衍生物、凱索尼酸(CA)、N-乙醯基葡萄糖胺(NAG)、熊果素、火龍果莖(DFS)萃取物和菸鹼酸(NCA)。在一定的濃度範圍內,它們皆能有效的抑制細胞黑色素生成或是抑制黑色素小體的傳遞。接著,我們進一步測試各成分的最佳濃度之共同效應。結果顯示,N-乙醯基葡萄糖胺、熊果素、火龍果莖萃取物三者相加的抑制黑色素程度最強烈,且並不會降低細胞存活率。另一方面,凱索尼酸與火龍果莖萃取物相加可能會產生分子間作用力而導致兩者抑制黑色素能力皆降低。然而,在共培養的實驗中,N-乙醯基葡萄糖胺、熊果素、菸鹼酸不加火龍果莖萃取物的抑制黑色素沈澱效果反而最佳,因此建議在四種成分之共同效應中,火龍果莖萃取物的濃度可能還要再降低。此外,我們也測試了L-抗壞血酸-2-磷酸(AA2P)於誘導人類皮膚纖維母細胞生成膠原蛋白的能力,以達到幫助傷口修復之目的。最後,我們提出了兩種最佳的組合成分於明膠膠中並應用於傷口修復。儘管我們建立的四種由傷口引發的發炎後過分黑色素沈澱之天竺鼠動物模型尚未完美,但因為我們在此研究中對各傷口種類及性質有了更深的了解,未來要找到一個可行的動物模型來驗證我們的APH gel之發明是可行的。zh_TW
dc.description.abstractThis study aimed to preclude and treat injury-induced post inflammatory hyperpigmentation (PIH) from the early to the late stage of wound care by incorporating depigmenting agents responsible for each inhibition states and wound healing agent in our anti-pigmentation healing gel (APH-gel). First, we examined some targeted lightening agents, including chitosan derivatives, chitosonic acid (CA), N-acetyl-D-glucosamine (NAG), arbutin, dragon fruit stem (DFS) extract, and nicotinamide (NCA) by B16F10 melanoma cells and human melanocyte-keratinocyte co-culture system. They all inhibited melanogenesis or melanosome transfer of cells under certain concentrations. Next, we tested their combined effects under their own best dosages. The results showed that the combination of NAG, arbutin, and DFS exhibited the strongest inhibitory effect on melanogenesis without diminishing cell viabilities. On the other hand, the combination of CA and DFS may undergo intermolecular interactions that hinder both of their efficacies. In co-culture experiments, however, the combination of NAG, arbutin, NCA was better without DFS for anti-pigmentation, thus a lower dosage of DFS was suggested. We also determined the best concentration of ascorbic acid-2-phosphate (AA2P) on collagen induction of human skin fibroblasts for healing purpose. Finally, we hypothesized two best gelatin gel formulas for wound healing applications. Although the four wound-induced PIH guinea pig models we established were still not perfect, finding a feasible animal model for future in vivo testing of our invention is possible with our new insights to different wound types and properties.en
dc.description.provenanceMade available in DSpace on 2021-07-11T15:47:53Z (GMT). No. of bitstreams: 1
ntu-107-R04548031-1.pdf: 29399822 bytes, checksum: f1b3091cd5d08834af7041ba535a6cb4 (MD5)
Previous issue date: 2018
en
dc.description.tableofcontents誌謝 i
中文摘要 ii
ABSTRACT iii
CONTENTS iv
LIST OF FIGURES viii
LIST OF TABLES ix
Chapter 1 Introduction 1
1.1 Post Inflammatory Hyperpigmentation 1
1.2 Wound Healing and Inflammation 2
1.3 Melanogenesis 3
1.4 PIH and UV Related Regulations for Melanogenesis 6
1.5 Current Treatment/Prevention for PIH 9
1.5.1 Photoprotection 9
1.5.2 Medicine Treatment 9
1.5.3 Surgical Therapy 9
1.5.4 Cosmetic Camouflage 10
1.6 Motives and Aims 10
1.7 Selected Agents 12
1.7.1 Tyrosinase Glycosylation Inhibitor 12
1.7.2 Tyrosinase Inhibitor 12
1.7.3 Melanosome Transfer Inhibitor 12
1.7.4 Wound Healing Aiding Agent 13
1.7.5 Antioxidantal, Anti-inflammatory Agent with Moisturizer 13
1.7.6 Gel Base 13
1.8 Animal Model 14
1.8.1 Guinea Pig 14
1.8.2 Cutaneous Wound 14
1.9 Research Framework 15
Chapter 2 Materials and Methods 16
2.1 Materials 16
2.1.1 Chemicals and Reagents 16
2.1.2 Cell Culture 17
2.1.3 Animal 18
2.1.4 Anesthetics 18
2.2 Experimental Equipment 18
2.3 Preparation of Treatment Solutions 19
2.4 In Vitro Anti-Hyperpigmentation Efficacy 19
2.4.1 Cell Culture 19
2.4.2 Cell Viability Test 20
2.4.3 Determination of Melanin Contents 21
2.4.4 Human Melanocyte/Keratinocyte Co-culture System 21
2.5 In Vitro Collagen Induction Efficacy 21
2.5.1 Cell Culture 21
2.5.2 Cell Viability Test 22
2.5.3 Collagen Type III Immunofluorescence Staining 22
2.5.4 Collagen Assay 23
2.6 Preparation of Anti-Pigmentation Healing Gel (APH Gel) 24
2.6.1 APH Gel Preparation 24
2.6.2 Characterization of Gelatin Gel 24
2.7 Wound-induced PIH Animal Model 24
2.7.1 Guinea Pig 24
2.7.2 Scratch-induced PIH Animal Model 24
2.7.3 Grinding-induced PIH Animal Model 24
2.7.4 Stripping-induced PIH Animal Model 25
2.7.5 Laser-induced PIH Animal Model 25
2.7.6 Dermination of Lightening Value 25
2.8 Statistical Analysis 25
Chapter 3 Results and Discussions 26
3.1 Dose-dependent Effects of Each Depigmenting Agents (Melanoma cells) 26
3.1.1 Chitosan Derivatives 26
3.1.2 Chitosonic Acid 27
3.1.3 N-Acetyl-D-Glucosamine 27
3.1.4 Arbutin 27
3.1.5 Dragon Fruit Stem Extract 28
3.2 Combined Effects of Selected Depigmenting Agents (Melanoma cells) 28
3.2.1 Chitosonic Acid with Arbutin 28
3.2.2 N-Acetyl-D-Glucosamine with Arbutin 28
3.2.3 Chitosonic Acid with Arbutin and Dragon Fruit Stem Extract 29
3.2.4 N-Acetyl-D-Glucosamine with Arbutin and Dragon Fruit Stem Extract 29
3.3 Dose-dependent Effects of Melanosome Transfer Inhibitor (Melanocyte-Keratinocyte co-culture system) 30
3.3.1 Nicotinamide 30
3.3.2 Nicotinamide with N-Acetyl-D-Glucosamine, Arbutin, and Dragon Fruit Stem Extract 30
3.4 Dose-dependent Effects of AA2P on Induction of Collagen Synthesis (Fibroblasts) 31
3.4.1 Immunofluorescence Staining of Type III Collagen 31
3.4.2 Cell Viability 31
3.4.3 Collagen Assay 31
3.5 Determination of Best Formula for APH Gel 32
3.5.1 APH-1 for Treatment Before Wound Closure (< 1 Week) 32
3.5.2 APH-2 for Treatment After Wound Closure (> 1 Week) 32
3.6 Characterization of APH Gel 33
3.6.1 Viscosity 33
3.7 Establishment of Wound-induced PIH Animal Model 33
3.7.1 Scratch-induced PIH Animal Model 33
3.7.2 Grinding-induced PIH Animal Model 33
3.7.3 Stripping-induced PIH Animal Model 34
3.7.4 Laser-induced PIH Animal Model 34
Chapter 4 Conclusion 35
FIGURES 36
TABLES 53
REFERENCE 55
dc.language.isoen
dc.subject火龍果zh_TW
dc.subject黑色素沈澱zh_TW
dc.subjectPIHzh_TW
dc.subject美白zh_TW
dc.subject傷口zh_TW
dc.subjectN-乙醯基葡萄糖胺zh_TW
dc.subject熊果素zh_TW
dc.subject凱索尼酸zh_TW
dc.subjectL-抗壞血酸-2-磷酸zh_TW
dc.subject菸鹼酸zh_TW
dc.subjectPIHen
dc.subjectN-acetyl-D-glucosamineen
dc.subjectwounden
dc.subjectpigmentationen
dc.subjectwhiteningen
dc.subjectdragon fruiten
dc.subjectnicotinamideen
dc.subjectascorbic acid-2-phosphateen
dc.subjectarbutinen
dc.subjectchitosonic aciden
dc.title褪黑凝膠於傷口修復及美白之應用zh_TW
dc.titleApplication of APH-Gel on Wound Healing and Skin Lighteningen
dc.typeThesis
dc.date.schoolyear106-2
dc.description.degree碩士
dc.contributor.oralexamcommittee賴君義(Juin-Yih Lai),王至弘(Jyh-Horng Wang),王大銘(Da-Ming Wang)
dc.subject.keyword黑色素沈澱,PIH,美白,傷口,N-乙醯基葡萄糖胺,熊果素,凱索尼酸,L-抗壞血酸-2-磷酸,菸鹼酸,火龍果,zh_TW
dc.subject.keywordpigmentation,PIH,whitening,wound,N-acetyl-D-glucosamine,chitosonic acid,arbutin,ascorbic acid-2-phosphate,nicotinamide,dragon fruit,en
dc.relation.page57
dc.identifier.doi10.6342/NTU201701764
dc.rights.note有償授權
dc.date.accepted2018-08-02
dc.contributor.author-college工學院zh_TW
dc.contributor.author-dept醫學工程學研究所zh_TW
dc.date.embargo-lift2023-08-06-
顯示於系所單位:醫學工程學研究所

文件中的檔案:
檔案 大小格式 
ntu-107-R04548031-1.pdf
  未授權公開取用
28.71 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved